申请人:Crew Andrew P.
公开号:US09133224B2
公开(公告)日:2015-09-15
Compounds of Formula (I): wherein variables are defined herein, and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers for which FAK inhibition is beneficial.
公式(I)的化合物:其中变量在此处定义,以及与之相关的药物可接受的盐,合成,中间体,配方和治疗该疾病的方法,包括FAK抑制对其有益的癌症。